The EPO published patent application EP4009966A1 for a scaleable polyketide preparation method developed by University of California researchers. The patent covers compositions and methods potentially useful in cancer treatment, classified under A61K 31/365 and A61P 35/02. The application designates all relevant European states including DE, FR, GB, IT, ES, NL, and others.

This is a routine patent publication notice with no immediate compliance requirements. Entities developing polyketide-based therapeutics should monitor this IP landscape and consider freedom-to-operate analyses. The patent grants exclusive rights to the claimed preparation methods, which may affect competitive R&D strategies in this area.